Vimta Labs Share Price
Start SIP in Vimta Labs
Start SIPVimta Labs Performance
Day Range
- Low 521
- High 547
52 Week Range
- Low 390
- High 700
- Open Price533
- Previous Close535
- Volume42750
Vimta Labs Investment Rating
-
Master Rating:
-
Vimta Labs has an operating revenue of Rs. 316.53 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 17% is great, ROE of 12% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -14% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 25 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 80 | 78 | 80 | 72 | 82 | 81 |
| Operating Expenses Qtr Cr | 57 | 55 | 59 | 57 | 58 | 57 |
| Operating Profit Qtr Cr | 24 | 24 | 21 | 15 | 24 | 24 |
| Depreciation Qtr Cr | 8 | 8 | 9 | 9 | 8 | 8 |
| Interest Qtr Cr | 0 | 1 | 1 | 1 | 0 | 0 |
| Tax Qtr Cr | 4 | 4 | 3 | 2 | 4 | 4 |
| Net Profit Qtr Cr | 12 | 12 | 9 | 6 | 12 | 12 |
Vimta Labs Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹573.93
- 50 Day
- ₹564.07
- 100 Day
- ₹540.54
- 200 Day
- ₹512.42
- 20 Day
- ₹597.73
- 50 Day
- ₹562.88
- 100 Day
- ₹529.27
- 200 Day
- ₹497.23
Vimta Labs Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 547.37 |
| Second Resistance | 559.53 |
| Third Resistance | 569.97 |
| RSI | 37.10 |
| MFI | 13.13 |
| MACD Single Line | 1.21 |
| MACD | -9.74 |
| Support | |
|---|---|
| First Support | 524.77 |
| Second Support | 514.33 |
| Third Supoort | 502.17 |
Vimta Labs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 38,630 | 2,436,780 | 63.08 |
| Week | 99,348 | 4,668,381 | 46.99 |
| 1 Month | 292,018 | 12,594,725 | 43.13 |
| 6 Month | 176,032 | 6,819,470 | 38.74 |
Vimta Labs Result Highlights
Vimta Labs Synopsis
NSE-Medical-Services
Vimta Labs Ltd. belongs to the Industry of Medical Research Services. Company’s Total Operating Revenue is Rs. 312.89 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2024. Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977.| Market Cap | 1,187 |
| Sales | 311 |
| Shares in Float | 1.40 |
| No of funds | 22 |
| Yield | 0.37 |
| Book Value | 3.75 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | 3 |
| Alpha | -0.15 |
| Beta | 1.12 |
Vimta Labs Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 36.89% | 36.92% | 36.98% | 37.01% |
| Mutual Funds | 1.49% | 1.49% | 1.49% | 1.49% |
| Foreign Portfolio Investors | 5.16% | 5.13% | 2.88% | 2.74% |
| Financial Institutions/ Banks | 0.01% | 0.01% | ||
| Individual Investors | 23.12% | 23.07% | 25.15% | 25% |
| Others | 33.34% | 33.38% | 33.5% | 33.75% |
Vimta Labs Management
| Name | Designation |
|---|---|
| Dr. Sivalinga Prasad Vasireddi | Executive Chairman |
| Ms. Harita Vasireddi | Managing Director |
| Mr. Harriman Vungal | Executive Director - Operations |
| Mr. Satya Sreenivas Neerukonda | Executive Director |
| Dr. Yadagiri R Pendri | Independent Director |
| Ms. Prameela Rani Yalamanchili | Independent Director |
| Mr. Sanjay Dave | Independent Director |
| Mr. Purnachandra Rao Gutta | Independent Director |
Vimta Labs Forecast
Price Estimates
Vimta Labs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-17 | Quarterly Results | |
| 2024-05-18 | Audited Results & Final Dividend | |
| 2024-03-30 | Amalgamation | |
| 2024-01-31 | Quarterly Results | |
| 2023-10-30 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-06-18 | FINAL | Rs.2.00 per share(100%)Dividend |
| 2021-06-28 | FINAL | Rs.2.00 per share(100%)Dividend |
Vimta Labs FAQs
What is Share Price of Vimta Labs ?
Vimta Labs share price is ₹524 As on 03 October, 2024 | 15:34
What is the Market Cap of Vimta Labs ?
The Market Cap of Vimta Labs is ₹1162.4 Cr As on 03 October, 2024 | 15:34
What is the P/E ratio of Vimta Labs ?
The P/E ratio of Vimta Labs is 28.3 As on 03 October, 2024 | 15:34
What is the PB ratio of Vimta Labs ?
The PB ratio of Vimta Labs is 3.6 As on 03 October, 2024 | 15:34